Delta neutrophil index as a predictive and prognostic factor for Candidemia patients: a matched case-control study

• Published in: BMC infectious diseases Vol. 20; no. 1; pp. 1 - 396
• Main Authors: Park, So Yeon, Lee, Jin Seo, Oh, Jihyu, Park, Ji-Young
• Format: Journal Article
• Language: English
• Published: London BioMed Central Ltd 05.06.2020; BioMed Central; BMC
• Subjects: Analysis; Antifungal agents; Automation; Bacterial diseases; Bacterial infections; Blood; Blood culture; Blood tests; Candidemia; Cardiac patients; Care and treatment; Colonization; Comorbidity; Control methods; Delta-neutrophil index (DNI); EDTA; Fungicides; Health aspects; Infection; Infections; Infectious diseases; Inflammation; Inflammatory response; Laboratories; Medical records; Medical research; Mortality; Multivariate analysis; Neutrophils; Nosocomial infections; Parenteral nutrition; Patients; Predictor; Prognosis; Prognostic factor; Regression analysis; Sepsis; Surgery; Systemic inflammatory response syndrome; United States > US
• ISSN: 1471-2334; 1471-2334
• DOI: 10.1186/s12879-020-05117-0

Delayed antifungal therapy for candidemia leads to increased mortality. Differentiating bacterial infection from candidemia in systemic inflammatory response syndrome (SIRS) patients is complex and difficult. The Delta Neutrophil Index (DNI) has recently been considered a new factor to distinguish infections from non-infections and predict the severity of sepsis. We aimed to assess if the DNI can predict and provide a prognosis for candidemia in SIRS patients. A matched case-control study was conducted from July 2016 to June 2017 at Kangdong Sacred Heart Hospital. Among patients with a comorbidity of SIRS, those with candidemia were classified as the case group, whereas those with negative blood culture results were classified as the control group. The matching conditions included age, blood culture date, and SIRS onset location. Multivariate logistic regression was performed to evaluate DNI as a predictive and prognostic factor for candidemia. The 140 included patients were assigned to each group in a 1:1 ratio. The DNI_D1 values measured on the blood culture date were higher in the case group than in the control group (p < 0.001). The results of multivariate analyses confirmed DNI_D1 (odds ratio [ORs] 2.138, 95% confidential interval [CI] 1.421-3.217, p < 0.001) and Candida colonization as predictive factors for candidemia. The cutoff value of DNI for predicting candidemia was 2.75%. The area under the curve for the DNI value was 0.804 (95% CI, 0.719-0.890, p < 0.001), with a sensitivity and specificity of 72.9 and 78.6%, respectively. Analysis of 14-day mortality in patients with candidemia showed significantly higher DNI_D1 and DNI_48 in the non-survivor group than in the survivor group. DNI was identified as a predictive factor for candidemia in patients with SIRS and a prognostic factor in predicting 14-day mortality in candidemia patients. DNI, along with clinical patient characteristics, was useful in determining the occurrence of candidemia in patients with SIRS.